Asahi Kaisei Corp (AHKSY) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Asahi Kaisei Corp stock $21.97, price $19.05, upside +15.3%, quality 60 out of 100. Rating: undervalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range $10.98 – $23.47 · fair‑value band $12.22 – $32.71 · the $19.05 price screens below the $21.97 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 9, 2026.
Follow Asahi Kaisei in your weekly email
Every Wednesday you see whether Asahi Kaisei is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Asahi Kasei Corporation engages in material, homes, healthcare businesses.
Show moreShow less
The company offers Pimel photosensitive polyimide/PBO precursor, a liquid photosensitive material for buffer coating and packaging applications; Sunfort dry film photoresist to form circuit patterns on printed wiring boards; Novacure, a latent curing agent for epoxy resin with storage stability; glass fabric for printed circuit boards; plastic optical fiber; suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; Hipore, a microporous polyolefin sheet which prevents the anode and cathode from contacting one another; Celgard, a lithium-ion battery separator; Deramic, a lead acid battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, ROICA, ELTAS, Bemliese, EUTEC, Precisé, SEMIA, smash, PULSHUT, Lastan, Cubit, NanoAct, ECORISE, BioCradle, CMC-Bemliese names.
It also provides cling film, bags and containers, and dishwashing liquid under the Saran Wrap, Ziploc, Cookper, Frosch names; packaging products under the OPS, Suntec, Barrialon, PVDC latex, and Saran names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names.
In addition, the company is involved in the provision of remodeling services; real estate-related operations; offers unit homes and apartment buildings; autoclaved aerated concrete, foundation systems, thermal insulation material, structural systems and components products; prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; enzymes and diagnostic products; and hemodialysis, therapeutic apheresis, and autologous blood-related businesses.
The company was founded in 1931 and is headquartered in Tokyo, Japan.
Stock analysis
Asahi Kaisei Corp (AHKSY) currently trades at $19.05, while our model-based Fair Value estimate is $21.97, implying the stock looks roughly 13% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $30.28 per share, and 7 of the 13 models we run sit above the $19.05 price.
Bear case: the Asset-Based group reads lowest at $7.47, and 6 of the 13 models stay below the price. Data coverage for this calculation is high.
Scenario range: $12.22 (bear) to $32.71 (bull), the price of $19.05 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Industrials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Asahi Kaisei Corp reported revenue of ¥3.3T in FY2026 versus ¥2.5T in FY2022, a compound +7.3%/yr. Reported net income was ¥168B in FY2026, compounding +1.0%/yr from FY2022.
Key figures
Market cap $12.9B Large · P/E ratio 10.4 · P/S ratio 0.53 · EPS (TTM) $1.84 · Dividend yield 2.6% · Net margin 5.2% · Return on equity 9.8% · Return on assets (EBIT) 5.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).
What moves the price
The share trades about 19% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at 8% fair-value upside, at 15%, AHKSY screens cheaper than that median.
Fair Value models
Bear$12.22Fair Value $21.97Bull$32.71
Price $19.05 · Upside +15.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then ($1.12 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.74/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+7.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.1%
Start year 2021 (pandemic). Over 10 years: +5.3% a year
Revenue growth 29 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.2%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in JPY (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+18.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+15.5%
Dividend (yield on the price)2.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.10.7% vs 5.1%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8% → 8%
2026 sits 92% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+8.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+2.3%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about +6.1% a year for the price and +0.2% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (99 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: The conglomerate's strength is its pharma unification targeting substantial healthcare growth by 2030, yet its weak point remains the anchoring materials and homes segments with cyclical exposure and limited durable advantage.
Main risk: Large-scale expansion of petrochemical capacity in China could continue to worsen the supply-demand balance, reduce prices and operating rates in basic materials businesses such as MMA, PMMA and related derivatives, and force further portfolio exits.
Asahi Kasei is unifying its acquired pharma units from Japan, the US, Europe and the recent AiCuris purchase under one global brand as it targets substantial healthcare revenue growth by 2030. Its materials and homes segments continue to anchor results amid broader cyclical exposure. Will the pharma buildout deliver faster earnings momentum than integration costs and materials volatility can contain?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Conglomerates · 304 stocks
Beats the industry median on 12/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside+15.3% · Above median
Profitability
Return on equity (12 months)9.8% · Above median
Return on assets4.1% · Above median
Net margin (12 months)6.1% · Below median
Operating margin (12 months)9.8% · Above median
Growth and dividend
Revenue growth (quarter YoY)11.9% · Above median
Dividend yield (12 months)2.6% · Above median
Balance sheet
Debt / equity0.40× · Above median
Valuation Multiplesvs Conglomerates median · lower = cheaper
P/E (12 months)10.4× · Cheaper than median
P/B0.97× · Cheaper than median
P/S (12 months)0.65× · Cheaper than median
Price / free cash flow (fiscal year)17.6× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Asahi Kaisei Corp (AHKSY) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of $21.97 versus a price of $19.05, about +15% upside (undervalued).
What is the fair value of AHKSY?
Our model-based fair value for Asahi Kaisei Corp is $21.97 (as of Nov 9, 2026), built from audited fundamentals. The current price: $19.05.
What is the quality score of AHKSY?
Asahi Kaisei Corp has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Asahi Kaisei Corp (AHKSY)?
Our model-based price target is the fair value of $21.97 (as of Nov 9, 2026) from 13 valuation models. Cautious scenario $12.22, optimistic scenario $32.71. It is a calculation from audited fundamentals, not an analyst target.
What is the Asahi Kaisei Corp stock forecast for 2026?
Our models put fair value at $21.97, about +15% upside versus a price of $19.05 (undervalued). Cautious scenario $12.22, optimistic scenario $32.71. The calculation is refreshed regularly with new filings.
What is the revenue of Asahi Kaisei Corp (AHKSY)?
Asahi Kaisei Corp reported trailing-twelve-month revenue of about ¥3.2T (latest available figure, as of Nov 9, 2026).
Does Asahi Kaisei Corp pay a dividend?
Asahi Kaisei Corp currently shows a dividend yield of 2.64% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Asahi Kaisei Corp (AHKSY) and when is the ex-dividend date?
Asahi Kaisei Corp has a dividend yield of 2.6%. The last ex-dividend date was Mar 31, 2026. A dividend has been paid every year since at least 2001. The payout ratio is 31.5% of earnings. Free cash flow covers the dividend 2.19 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Asahi Kaisei Corp (AHKSY)?
For today's price to be fair in a discounted-cash-flow model, Asahi Kaisei Corp would have to grow free cash flow by +8.3 % per year for five years (discount rate 8.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.1 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of AHKSY use?
Our models discount Asahi Kaisei Corp at 8.4 %: a base by market capitalisation (large), damped by beta 0.66, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Asahi Kaisei Corp that is +8.3 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.4 %) and the same formula as our fair value.
How much growth has Asahi Kaisei Corp (AHKSY) delivered so far?
Over the past 5 years revenue at Asahi Kaisei Corp grew +9.1 % a year. The price currently implies free-cash-flow growth of +8.3 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Asahi Kaisei Corp (AHKSY) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Asahi Kaisei Corp (+8.3 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Asahi Kaisei Corp (AHKSY)?
The free-cash-flow yield on the price is 5.70 %: that much free cash flow Asahi Kaisei Corp produces per unit of market value. When it exceeds the discount rate of our models (8.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Asahi Kaisei Corp (AHKSY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Asahi Kaisei Corp it is $21.97 per share (as of Nov 9, 2026), against a price of $19.05. It is the blended result of 13 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Asahi Kaisei Corp stock overvalued or undervalued in 2026?
As of Nov 9, 2026, AHKSY trades below its calculated fair value: price $19.05, fair value $21.97, a gap of about +15% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AHKSY?
No. The price is what the market pays today ($19.05); the fair value is what the company's own numbers justify ($21.97). For Asahi Kaisei Corp the two are $2.92 per share apart. That gap is exactly why we show both numbers side by side.
How much is Asahi Kaisei Corp worth?
The market values Asahi Kaisei Corp at about $12.9B (market capitalisation, as of Nov 9, 2026). Per share that is $19.05; our models calculate a fair value of $21.97 per share.
What do the bullish and bearish scenarios say about AHKSY?
Our models span a range for Asahi Kaisei Corp: cautious scenario $12.22, base $21.97, optimistic $32.71 per share (as of Nov 9, 2026, price $19.05). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AHKSY?
Asahi Kaisei Corp trades at a price-to-earnings ratio of 10.4 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $21.97 is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2017 to 2026), reported earnings: 11.7. Other multiples: PEG 0.1, P/B 1.0, P/S 0.6, EV/EBITDA 5.4.
What is the PEG ratio of AHKSY?
The PEG ratio of Asahi Kaisei Corp is 0.11 (P/E divided by earnings growth, as of Nov 9, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Asahi Kaisei Corp (AHKSY)?
Balance-sheet figures for Asahi Kaisei Corp (as of Nov 9, 2026): return on equity 9.8%, debt of 0.40 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is AHKSY from its 52-week high?
Asahi Kaisei Corp trades at $19.05, about 19% below its 52-week high of $23.47 and 21% above the low of $15.71 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $21.97 is for.
Which stocks are comparable to Asahi Kaisei Corp?
From the same area (Industrials) we also value 3M Company, Honeywell International Inc, Swire Pacific Limited, SGH Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Asahi Kaisei Corp stock attractive at the current price?
The data as of Nov 9, 2026: price $19.05, calculated fair value $21.97 (+15%), Quality Score 60/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AHKSY calculated?
We run Asahi Kaisei Corp through 13 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of $21.97 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Asahi Kaisei Corp currently trades 13% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Asahi Kaisei Corp (AHKSY)?
The closing price on Nov 6, 2026 was $19.05. Our model-based fair value is $21.97, about +15% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Asahi Kaisei Corp right now?
The model range is unusually wide ($12.22 to $32.71). The outcome hinges heavily on assumptions, so read the point estimate with caution. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Asahi Kaisei Corp (AHKSY) come from?
Earnings per share at Asahi Kaisei Corp grew +1.4 % a year from 2015 to 2026. Broken into its drivers: revenue per share +5.3 %, EBIT margin −2.5 %, tax rate +1.7 %, residual (interest, one-offs) −2.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Asahi Kaisei Corp
How large is the market capitalisation of Asahi Kaisei Corp (AHKSY)?
The market capitalisation of Asahi Kaisei Corp is $12.9B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Asahi Kaisei Corp (AHKSY)?
The price-to-sales ratio of Asahi Kaisei Corp is 0.53 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Asahi Kaisei Corp (AHKSY)?
Earnings per share at Asahi Kaisei Corp are $1.84 (price ÷ EPS = P/E 10.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Asahi Kaisei Corp (AHKSY)?
The dividend yield of Asahi Kaisei Corp is 2.6% (payout 27.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Asahi Kaisei Corp (AHKSY)?
The net margin of Asahi Kaisei Corp is 5.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Asahi Kaisei Corp (AHKSY)?
The return on equity (ROE) of Asahi Kaisei Corp is 9.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Asahi Kaisei Corp (AHKSY)?
On an EBIT basis the return on assets of Asahi Kaisei Corp is 5.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Asahi Kaisei Corp (AHKSY)?
The operating margin of Asahi Kaisei Corp is 9.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Asahi Kaisei Corp (AHKSY)?
Revenue at Asahi Kaisei Corp is growing +11.9% versus a year earlier (3y avg +6.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Asahi Kaisei Corp (AHKSY)?
Earnings per share at Asahi Kaisei Corp are growing +174% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Asahi Kaisei Corp (AHKSY) carry?
The net debt of Asahi Kaisei Corp is ¥637B (fiscal year 2026, ≈ 5.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Asahi Kaisei Corp in the live analysis
One click puts Asahi Kaisei Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 9, 2026